Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES SUN PHARMA ZYDUS LIFESCIENCES/
SUN PHARMA
 
P/E (TTM) x 20.6 55.2 37.3% View Chart
P/BV x 2.4 4.9 50.0% View Chart
Dividend Yield % 0.6 1.0 59.6%  

Financials

 ZYDUS LIFESCIENCES   SUN PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
SUN PHARMA
Mar-22
ZYDUS LIFESCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs674931 72.4%   
Low Rs331593 55.9%   
Sales per share (Unadj.) Rs149.1161.1 92.6%  
Earnings per share (Unadj.) Rs22.714.2 160.1%  
Cash flow per share (Unadj.) Rs29.723.1 128.4%  
Dividends per share (Unadj.) Rs2.5010.00 25.0%  
Avg Dividend yield %0.51.3 37.9%  
Book value per share (Unadj.) Rs166.1200.1 83.0%  
Shares outstanding (eoy) m1,023.742,399.34 42.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.44.7 71.3%   
Avg P/E ratio x22.153.7 41.2%  
P/CF ratio (eoy) x16.932.9 51.4%  
Price / Book Value ratio x3.03.8 79.5%  
Dividend payout %11.070.4 15.6%   
Avg Mkt Cap Rs m514,2771,827,693 28.1%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77773,008 29.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652386,545 39.5%  
Other income Rs m2,35414,374 16.4%   
Total revenues Rs m155,006400,919 38.7%   
Gross profit Rs m34,42753,150 64.8%  
Depreciation Rs m7,13021,437 33.3%   
Interest Rs m1,2701,274 99.7%   
Profit before tax Rs m28,38144,813 63.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,11710,755 47.6%   
Profit after tax Rs m23,26434,058 68.3%  
Gross profit margin %22.613.7 164.0%  
Effective tax rate %18.024.0 75.1%   
Net profit margin %15.28.8 173.0%  
BALANCE SHEET DATA
Current assets Rs m122,614350,150 35.0%   
Current liabilities Rs m78,394172,006 45.6%   
Net working cap to sales %29.046.1 62.9%  
Current ratio x1.62.0 76.8%  
Inventory Days Days93149 62.2%  
Debtors Days Days80100 79.8%  
Net fixed assets Rs m144,382318,882 45.3%   
Share capital Rs m1,0242,399 42.7%   
"Free" reserves Rs m168,972477,713 35.4%   
Net worth Rs m169,996480,112 35.4%   
Long term debt Rs m3,6212,299 157.5%   
Total assets Rs m266,996669,032 39.9%  
Interest coverage x23.336.2 64.5%   
Debt to equity ratio x00 444.8%  
Sales to assets ratio x0.60.6 99.0%   
Return on assets %9.25.3 174.0%  
Return on equity %13.77.1 192.9%  
Return on capital %17.19.6 178.8%  
Exports to sales %00-   
Imports to sales %14.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,869NA-   
Fx inflow Rs m63,065106,331 59.3%   
Fx outflow Rs m21,86971,874 30.4%   
Net fx Rs m41,19634,456 119.6%   
CASH FLOW
From Operations Rs m21,04189,845 23.4%  
From Investments Rs m11,544-57,247 -20.2%  
From Financial Activity Rs m-8,683-51,935 16.7%  
Net Cashflow Rs m23,729-17,648 -134.5%  

Share Holding

Indian Promoters % 75.0 54.5 137.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.5 35.6 43.6%  
FIIs % 2.6 16.0 16.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.5 55.0%  
Shareholders   408,231 643,512 63.4%  
Pledged promoter(s) holding % 0.0 2.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    PIRAMAL ENTERPRISES    


More on Cadila Healthcare vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Sun Pharma Share Price Performance

Period Cadila Healthcare Sun Pharma S&P BSE HEALTHCARE
1-Day 1.49% -3.57% -0.89%
1-Month -8.17% -3.14% -1.85%
1-Year -10.96% 29.49% -6.83%
3-Year CAGR 16.63% 31.95% 20.56%
5-Year CAGR -0.30% 13.47% 10.73%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Sun Pharma paid Rs 10.0, and its dividend payout ratio stood at 70.4%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.